Canton Biologics

Founded in 2016, Canton biologics is a one-stop international CDMO company that focuses on providing bio-pharmaceutical development, manufacturing, and supply chain services for global innovative pharmaceutical enterprises. With excellent technology and reliable delivery, we accelerate the high-quality research and development of biologics for partners, reduce costs, and benefit public health and life. We have six R&D Manufacture centers in China and Europe and own a team of more than 300 scientists with over 15 years of pharmaceutical experience. Furthermore, over 60% of our researchers and developers are masters and doctors. As a highly efficient company, we have created a new record that from DNA to CMC in only 7 months, which has played an important role in the rapid advancement of customers' products to clinical practice. In addition, we have 13+5 manufacturing lines complying with China, US and EU GMP standard batch, fed-batch, perfusion) for DS and DP manufacturing. Service Offerings: Biologics CDMO,covering Monoclonal Antibody, Bispecific Antibody, Fusion Protein, Recombinant Protein, Vaccine Cell and Gene TherapyCGTCDMO